Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Limited Stage Small Cell Lung Cancer × trilaciclib × 90 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 2 Pathologic Complete Response 1 Neoplasms 1 Neoplasm Metastasis 1 Limited Stage Small Cell Lung Cancer 1 Hemangiosarcoma 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

trilaciclib 1 durvalumab 1 Sodium Chloride 1 Probiotics 1 Immunotherapy 1 Glucose 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07473128 2026-03-16

Effect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage Small Cell Lung Cancer

Pharmacosmos A/S

Phase 3 Not yet recruiting

Limited Stage Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡